Female, Mammary Duct Ectasia of Unspecified Breast, Mammographic Findings
Conditions
Keywords
mammography, ductal ectasia, breast neoplasm/diagnostic imaging, mammary Glands, Human/pathology, female
Brief summary
Mammograms performed at the Diagnostic Imaging Department of the Instituto Brasileiro de Controle do Câncer (IBCC - Brazilian Cancer Control Institute) will be prospectively evaluated. Patients who present a solitary dilated duct visualized by mammography will be submitted to breast ultrasonography. In case of detection of lesion, a percutaneous biopsy will be performed.
Detailed description
Purpose: To determinate the incidence, pathological significance and risk factors associated with the presence of solitary dilated duct visualized at mammography exam. Methods: Mammograms performed at the Diagnostic Imaging Department of the Instituto Brasileiro de Controle do Câncer (IBCC - Brazilian Cancer Control Institute) will be prospectively evaluated. Patients who present a solitary dilated duct visualized by mammography will be included in the study. These patients will be recalled in order to be submitted to an ultrasonography directed to the mammographic finding. Patients who present lesions on ultrasonography will undergo method-guided percutaneous biopsy. Patients with ductal ectasia, without evident lesions, will be followed for 2 years to evaluate stability by means of mammography or ultrasonography every 6-month intervals.
Interventions
Group No ductal lesion will be submitted to follow-up with periodic breast ultrasonography/mammography every 6 months for 2 years.
Group Ductal lesion will be submitted to ultrasound-guided percutaneous biopsy and the specimen will be histologically analysed.
Sponsors
Study design
Eligibility
Inclusion criteria
* Identification of a solitary dilated breast duct at mammography
Exclusion criteria
* Previous breast surgery at same side of detection of dilated duct
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Abnormal histological finding at breast biopsy | At guided-percutaneous biopsy | Detection of any histological abnormality |